{
    "title": "How one Indian company could be world's door to a COVID-19 vaccine",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8348593/How-one-Indian-company-worlds-door-COVID-19-vaccine.html",
    "date": "2020-05-22",
    "keywords": [
        "vaccine",
        "poonawalla",
        "serum",
        "government",
        "world",
        "covid19",
        "institute",
        "shaligram",
        "development",
        "chance",
        "coronavirus",
        "company",
        "companys",
        "team",
        "year",
        "roy",
        "rocha",
        "access",
        "university",
        "day",
        "message",
        "race",
        "everything",
        "india",
        "role",
        "city",
        "disease",
        "azd1222",
        "country",
        "dose",
        "glass",
        "advance",
        "value",
        "hype",
        "facility",
        "pandemiclevel",
        "stake",
        "pune",
        "manufacturer",
        "volume",
        "astrazenecaoxford",
        "head",
        "research",
        "employer",
        "midnight",
        "k",
        "minister",
        "modis",
        "adviser",
        "indication",
        "nature",
        "progress",
        "report",
        "import",
        "night",
        "attention",
        "developer",
        "executive",
        "adar",
        "campus",
        "activity",
        "push",
        "number",
        "way",
        "none",
        "family",
        "maker",
        "scale",
        "availability",
        "battle",
        "oneupmanship",
        "office",
        "familys",
        "farm",
        "cyrus",
        "codagenix",
        "themis",
        "candidate",
        "works",
        "oxford",
        "astrazeneca",
        "trial",
        "stage",
        "chadox1",
        "month",
        "june",
        "stock",
        "highrisk",
        "globe",
        "octobernovember",
        "success",
        "platform",
        "information",
        "booster",
        "charge",
        "inhouse",
        "treatment",
        "immune",
        "response",
        "system"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}